Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Autor: Nakamura, Yasuhiro, Namikawa, Kenjiro, Kiniwa, Yukiko, Kato, Hiroshi, Yamasaki, Osamu, Yoshikawa, Shusuke, Maekawa, Takeo, Matsushita, Shigeto, Takenouchi, Tatsuya, Inozume, Takashi, Nakai, Yasuo, Fukushima, Satoshi, Saito, Shintaro, Otsuka, Atsushi, Fujimoto, Noriki, Isei, Taiki, Baba, Natsuki, Matsuya, Taisuke, Tanaka, Ryo, Kaneko, Takahide, Onishi, Masazumi, Kuwatsuka, Yutaka, Nagase, Kotaro, Onuma, Takehiro, Nomura, Motoo, Umeda, Yoshiyasu, Yamazaki, Naoya
Zdroj: In European Journal of Cancer November 2022 176:78-87
Databáze: ScienceDirect
Externí odkaz: